383 related articles for article (PubMed ID: 22908106)
21. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.
Fattal-Valevski A; Kesler A; Sela BA; Nitzan-Kaluski D; Rotstein M; Mesterman R; Toledano-Alhadef H; Stolovitch C; Hoffmann C; Globus O; Eshel G
Pediatrics; 2005 Feb; 115(2):e233-8. PubMed ID: 15687431
[TBL] [Abstract][Full Text] [Related]
22. Dissociation of clinical and laboratory diagnosis in hypothyroidism.
Bajaj S; Sharma GP; Kumar D; Mehrotra R
J Assoc Physicians India; 2005 Jan; 53():15-8. PubMed ID: 15857005
[TBL] [Abstract][Full Text] [Related]
23. Differences in screening and confirmatory thyroid profiles in congenital hypothyroid subtypes: implications for missed cases.
MacMillan DR; Mabry CC
J Perinatol; 1995; 15(2):126-30. PubMed ID: 7595770
[TBL] [Abstract][Full Text] [Related]
24. Similar age-dependent levothyroxine requirements of schoolchildren with congenital or acquired hypothyroidism.
Perlsteyn M; Deladoëy J; Van Vliet G
Eur J Pediatr; 2016 Jun; 175(6):869-72. PubMed ID: 26856857
[TBL] [Abstract][Full Text] [Related]
25. Soy isoflavones inducing overt hypothyroidism in a patient with chronic lymphocytic thyroiditis: a case report.
Nakamura Y; Ohsawa I; Goto Y; Tsuji M; Oguchi T; Sato N; Kiuchi Y; Fukumura M; Inagaki M; Gotoh H
J Med Case Rep; 2017 Sep; 11(1):253. PubMed ID: 28870235
[TBL] [Abstract][Full Text] [Related]
26. Optimal daily levothyroxine dose in primary hypothyroidism. Its relation to pretreatment thyroid hormone indexes.
Kabadi UM
Arch Intern Med; 1989 Oct; 149(10):2209-12. PubMed ID: 2508585
[TBL] [Abstract][Full Text] [Related]
27. Levothyroxine requirement in congenital hypothyroidism: a 12-year longitudinal study.
Delvecchio M; Salerno M; Vigone MC; Wasniewska M; Popolo PP; Lapolla R; Mussa A; Tronconi GM; D'Acunzo I; Di Mase R; Falcone RM; Corrias A; De Luca F; Weber G; Cavallo L; Faienza MF
Endocrine; 2015 Dec; 50(3):674-80. PubMed ID: 25762444
[TBL] [Abstract][Full Text] [Related]
28. Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism.
Cassio A; Monti S; Rizzello A; Bettocchi I; Baronio F; D'Addabbo G; Bal MO; Balsamo A
J Pediatr; 2013 Jun; 162(6):1264-9, 1269.e1-2. PubMed ID: 23312689
[TBL] [Abstract][Full Text] [Related]
29. Use of soy protein supplement and resultant need for increased dose of levothyroxine.
Bell DS; Ovalle F
Endocr Pract; 2001; 7(3):193-4. PubMed ID: 11421567
[TBL] [Abstract][Full Text] [Related]
30. Noncompliance with medical treatment: pseudomalabsorption of levothyroxine.
Eledrisi MS; Szymajda A; Alshanti M; Urban RJ
South Med J; 2001 Aug; 94(8):833-6. PubMed ID: 11549198
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune thyroiditis with severe hypothyroidism resistant to the treatment with high peroral doses of thyroxine: case report.
Payer J; Sladekova K; Kinova S; Cesnakova Z; Killinger Z; Krizko M; Klimes I; Langer P
Endocr Regul; 2000 Dec; 34(4):189-93. PubMed ID: 11137979
[TBL] [Abstract][Full Text] [Related]
32. Overt and subclinical hypothyroidism complicating pregnancy.
Abalovich M; Gutierrez S; Alcaraz G; Maccallini G; Garcia A; Levalle O
Thyroid; 2002 Jan; 12(1):63-8. PubMed ID: 11838732
[TBL] [Abstract][Full Text] [Related]
33. [The course of pregnancy in congenital thyroid gland aplasia. Case report with special reference to maternal hypothyroidism].
Bolz M; Nagel H
Zentralbl Gynakol; 1994; 116(9):515-21. PubMed ID: 7975962
[TBL] [Abstract][Full Text] [Related]
34. Prediction of Transient or Permanent Congenital Hypothyroidism from Initial Thyroid Stimulating Hormone Levels.
Scavone M; Carboni E; Stefanelli E; Romano G; Vero A; Giancotti L; Miniero R; Talarico V
Indian Pediatr; 2018 Dec; 55(12):1059-1061. PubMed ID: 30745478
[TBL] [Abstract][Full Text] [Related]
35. Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine.
Peroni E; Vigone MC; Mora S; Bassi LA; Pozzi C; Passoni A; Weber G
Horm Res Paediatr; 2014; 81(1):50-4. PubMed ID: 24247169
[TBL] [Abstract][Full Text] [Related]
36. Levothyroxine dosage is associated with stability of thyroid-stimulating hormone values.
Pecina J; Garrison GM; Bernard ME
Am J Med; 2014 Mar; 127(3):240-5. PubMed ID: 24333203
[TBL] [Abstract][Full Text] [Related]
37. Homozygous DUOXA2 mutation (p.Tyr138
Sugisawa C; Higuchi S; Takagi M; Hasegawa Y; Taniyama M; Abe K; Hasegawa T; Narumi S
Endocr J; 2017 Aug; 64(8):807-812. PubMed ID: 28626131
[TBL] [Abstract][Full Text] [Related]
38. Thyroid dysfunction in HIV-infected children: is L-thyroxine therapy beneficial?
Rana S; Nunlee-Bland G; Valyasevi R; Iqbal M
Pediatr AIDS HIV Infect; 1996 Dec; 7(6):424-8. PubMed ID: 11361500
[TBL] [Abstract][Full Text] [Related]
39. In congenital hypothyroidism, an initial L-thyroxine dose of 10-12 μg/kg/day is sufficient and sometimes excessive based on thyroid tests 1 month later.
Vaidyanathan P; Pathak M; Kaplowitz PB
J Pediatr Endocrinol Metab; 2012; 25(9-10):849-52. PubMed ID: 23426811
[TBL] [Abstract][Full Text] [Related]
40. Imatinib induces hypothyroidism in patients receiving levothyroxine.
de Groot JW; Zonnenberg BA; Plukker JT; van Der Graaf WT; Links TP
Clin Pharmacol Ther; 2005 Oct; 78(4):433-8. PubMed ID: 16198662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
